Painter Jodie N, Savander Miia, Ropponen Anne, Nupponen Nina, Riikonen Seija, Ylikorkala Olavi, Lehesjoki Anna-Elina, Aittomäki Kristiina
Folkhälsan Institute of Genetics, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Eur J Hum Genet. 2005 Apr;13(4):435-9. doi: 10.1038/sj.ejhg.5201355.
Intrahepatic cholestasis of pregnancy (ICP) is a cholestatic condition that may affect women during the third trimester of pregnancy. Symptoms experienced by these women generally resolve spontaneously following delivery, but prior to delivery the fetus is at increased risk of intrauterine distress and sudden intrauterine death. The genetic etiology of most cases of ICP is unknown, although heterozygous carriers of mutations causing progressive familial intrahepatic cholestasis (PFIC) diseases may experience ICP. When examining linkage to known cholestasis genes, affected members of four Finnish ICP families shared haplotypes around ATP8B1, the gene responsible for PFIC1. This gene was subsequently screened in 176 familial and sporadic ICP patients. A total of 17 sequence changes were detected, five exonic and 12 intronic. No intronic change was associated with ICP in sporadic cases. Four intronic changes segregated with ICP in three families, a different change in each of two families and three changes in another family, although the significance of this is currently unknown. Three exonic changes were nonsynonymous, one (in exon 23) is probably a polymorphism while two predict novel amino-acid replacements (N45T and K203R). These changes, in exons 2 and 7, were detected in one individual each, and may have predisposed these individuals to ICP. In conclusion, although the exon 2 and 7 changes may have functioned as risk alleles, ATP8B1 is probably not a major gene contributing to the occurrence of ICP.
妊娠期肝内胆汁淤积症(ICP)是一种胆汁淤积性疾病,可能在妊娠晚期影响女性。这些女性出现的症状通常在分娩后会自发缓解,但在分娩前胎儿发生宫内窘迫和宫内猝死的风险会增加。尽管导致进行性家族性肝内胆汁淤积症(PFIC)疾病的突变杂合携带者可能会患ICP,但大多数ICP病例的遗传病因尚不清楚。在研究与已知胆汁淤积症基因的连锁关系时,四个芬兰ICP家族的患病成员在ATP8B1(负责PFIC1的基因)周围共享单倍型。随后对176例家族性和散发性ICP患者进行了该基因的筛查。共检测到17个序列变化,其中5个在外显子,12个在内含子。散发性病例中没有内含子变化与ICP相关。在三个家族中,四个内含子变化与ICP共分离,两个家族各有一个不同的变化,另一个家族有三个变化,尽管其意义目前尚不清楚。三个外显子变化是非同义的,一个(在外显子23中)可能是多态性,而另外两个预测有新的氨基酸替代(N45T和K203R)。这些在外显子2和7中的变化分别在一个个体中检测到,可能使这些个体易患ICP。总之,尽管外显子2和7的变化可能起到了风险等位基因的作用,但ATP8B1可能不是导致ICP发生的主要基因。